Tim Nielsen

Tim Nielsen has extensive experience in medical affairs, currently serving as the Medical Manager at Celltrion Healthcare Co., Ltd. since October 2021, where the focus is on launching Remsima SC and YUFLYMA in gastroenterology and rheumatology. Prior roles include Senior Medical Science Liaison at Janssen Pharmaceutical Companies from July 2018 to September 2021, supporting Inflammatory Bowel Disease treatments, and National Medical Science Liaison at MSD Australia & New Zealand, contributing to the launch of anti-TNF biosimilars. Tim's background includes a Medical Liaison position in respiratory and sleep medicine, as well as various research roles in esteemed institutions, culminating in a PhD in Biochemistry and Cell Biology from the University of Adelaide.